Cargando…
Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection
This study presents a comprehensive comparative study of different green spectrophotometric approaches without any physical separation on processing a ternary mixture of Aceclofenac (ACE), Paracetamol (PAR) and Rabeprazole (RAB) in combined medicine for managing tough symptoms in the COVID-19 Pandem...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759764/ https://www.ncbi.nlm.nih.gov/pubmed/35483258 http://dx.doi.org/10.1016/j.saa.2022.121256 |
_version_ | 1784852304525000704 |
---|---|
author | Ahmed, Dina A. Lotfy, Hayam M. |
author_facet | Ahmed, Dina A. Lotfy, Hayam M. |
author_sort | Ahmed, Dina A. |
collection | PubMed |
description | This study presents a comprehensive comparative study of different green spectrophotometric approaches without any physical separation on processing a ternary mixture of Aceclofenac (ACE), Paracetamol (PAR) and Rabeprazole (RAB) in combined medicine for managing tough symptoms in the COVID-19 Pandemic. The different univariate complementary resolutions according to the response used for the assay of the cited drugs after applying the processing steps were implemented using successive in-silico sample enrichment for resolving the ternary mixture via different windows of spectrophotometric platform using sticking - pulling strategy (SPS). Window I; based on manipulation of the data of zero order absorption spectrum of the mixture using novel Extended absorbance difference (EAD) and Absorbance difference (AD) methods coupled with corresponding spectrum subtraction method (SS). Window III; based on manipulation of the data of ratio spectra via Constant value coupled with constant subtraction (CV-CS) and novel Induced dual amplitude difference (IDAD) method coupled with corresponding spectrum subtraction method (SS). Finally, window IV; based on manipulation of the data of derivative of the ratio spectrum of the mixture via novel Factorized derivative ratio null contribution (FDD-NC) and Factorized unlimited derivative ratio (FUDD) methods coupled with corresponding spectrum subtraction method (SS). Synthetic mixtures and commercial medicine were constructively analyzed using the proposed methods while maintaining calibration graphs to be linear over ranges; 4.0–40.0 µg/mL for ACE, 2.0–14.0 µg/mL for PAR and 4.0–30.0 µg/mL for RAB. Moreover, methods' validation was confirmed via performing exhaustive statistical treatment of the experimental findings. The proposed methodologies can be used for the routine analysis of the cited drugs in quality control laboratories. Additionally, Spectral Similarity Index (SSI) was calculated to detect counterfeit products and methods’ greenness profile was finally guaranteed through analytical greenness (AGREE) metric assessment tool. |
format | Online Article Text |
id | pubmed-9759764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97597642022-12-19 Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection Ahmed, Dina A. Lotfy, Hayam M. Spectrochim Acta A Mol Biomol Spectrosc Article This study presents a comprehensive comparative study of different green spectrophotometric approaches without any physical separation on processing a ternary mixture of Aceclofenac (ACE), Paracetamol (PAR) and Rabeprazole (RAB) in combined medicine for managing tough symptoms in the COVID-19 Pandemic. The different univariate complementary resolutions according to the response used for the assay of the cited drugs after applying the processing steps were implemented using successive in-silico sample enrichment for resolving the ternary mixture via different windows of spectrophotometric platform using sticking - pulling strategy (SPS). Window I; based on manipulation of the data of zero order absorption spectrum of the mixture using novel Extended absorbance difference (EAD) and Absorbance difference (AD) methods coupled with corresponding spectrum subtraction method (SS). Window III; based on manipulation of the data of ratio spectra via Constant value coupled with constant subtraction (CV-CS) and novel Induced dual amplitude difference (IDAD) method coupled with corresponding spectrum subtraction method (SS). Finally, window IV; based on manipulation of the data of derivative of the ratio spectrum of the mixture via novel Factorized derivative ratio null contribution (FDD-NC) and Factorized unlimited derivative ratio (FUDD) methods coupled with corresponding spectrum subtraction method (SS). Synthetic mixtures and commercial medicine were constructively analyzed using the proposed methods while maintaining calibration graphs to be linear over ranges; 4.0–40.0 µg/mL for ACE, 2.0–14.0 µg/mL for PAR and 4.0–30.0 µg/mL for RAB. Moreover, methods' validation was confirmed via performing exhaustive statistical treatment of the experimental findings. The proposed methodologies can be used for the routine analysis of the cited drugs in quality control laboratories. Additionally, Spectral Similarity Index (SSI) was calculated to detect counterfeit products and methods’ greenness profile was finally guaranteed through analytical greenness (AGREE) metric assessment tool. Elsevier B.V. 2022-09-05 2022-04-20 /pmc/articles/PMC9759764/ /pubmed/35483258 http://dx.doi.org/10.1016/j.saa.2022.121256 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ahmed, Dina A. Lotfy, Hayam M. Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection |
title | Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection |
title_full | Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection |
title_fullStr | Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection |
title_full_unstemmed | Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection |
title_short | Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection |
title_sort | sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in covid-19 pandemic using different windows of spectrophotometric platform-counterfeit products' detection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759764/ https://www.ncbi.nlm.nih.gov/pubmed/35483258 http://dx.doi.org/10.1016/j.saa.2022.121256 |
work_keys_str_mv | AT ahmeddinaa stickingpullingstrategyforassessmentofcombinedmedicineformanagementoftoughsymptomsincovid19pandemicusingdifferentwindowsofspectrophotometricplatformcounterfeitproductsdetection AT lotfyhayamm stickingpullingstrategyforassessmentofcombinedmedicineformanagementoftoughsymptomsincovid19pandemicusingdifferentwindowsofspectrophotometricplatformcounterfeitproductsdetection |